Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 June, 2018 23:20 IST
ICRA downgrades rating on UCO Bank's bonds programme
Source: IRIS | 21 Jun, 2017, 08.50AM
Comments  |  Post Comment

The ratings downgrade take into account UCO's weak operating and financial performance during Q4FY2017 and in FY2017 overall. Driven by consecutive years of losses during last two fiscals, and high levels of non-performing assets (NPA), the capitalisation levels and solvency profile remain weak for the bank.

It also takes into account the unfavourable outlook on the bank's profitability amid high NPAs and the consequent challenges which the bank is likely to face to meet the increasing capital requirements under Basel III regulations.

The bank's asset quality remains weak with gross and net NPAs of 17.13% and 8.94% respectively as on March 31, 2017 as compared with 15.44% and 9.09% respectively as on March 31, 2016. With the standstill clause being applicable on asset classification under various schemes on resolution of stressed assets, UCO has a large number of loans continuing to be classified as standard accounts.

Hence the reported asset quality is likely to deteriorate further going forward. The rise in NPAs and the consequent income reversals led to a decline in the bank's net interest income (NII) by 21.27% in FY2017.

The bank's operating expenses also increased by 5.78% during the year. UCO's core operating profits consequently declined by 41.8% to Rs 16.85 billion, which were not adequate to absorb the high credit provisions during the year, resulting in a net loss of Rs 18.50 billion during FY2017.

Shares of the bank declined Rs 0.55, or 1.57%, to settle at Rs 34.50. The total volume of shares traded was 80,145 at the BSE (Tuesday).



Uco Bank   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Cipla receives final approval for generic Sustiva - 19-Jun-2018 16:22
Dr. Reddy's Lab launches Levetiracetam in NaCl injection - 19-Jun-2018 12:23
Zydus Cadila receives tentative approval for Tadalafil tablets - 19-Jun-2018 12:22
Tata Power partners IDFC Bank for digitized solution in Mumbai - 19-Jun-2018 11:21
ICICI Bank board appoints Sandeep Bakhshi as COO - 19-Jun-2018 11:00
Cords Cable wins bulk order worth Rs 472 mn - 19-Jun-2018 09:59
Glenmark Pharma gets approval for North California facility - 19-Jun-2018 09:55
Strides Shasun receives USFDA nod for Ketoconazole tablets - 19-Jun-2018 09:50
Dr. Reddy's defends right to launch Buprenorphine and Naloxone Sublingual Film - 18-Jun-2018 12:40
Lupin, Nichi-Iko in pact for commercialisation of Etanercept in Japan - 18-Jun-2018 11:38
Yes Bank gets SEBI approval for offering custodial services - 18-Jun-2018 10:06
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer